Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1995-06-07
1997-08-26
Chang, Ceila
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
514278, 546 20, 546208, A61K 31445
Patent
active
056611609
ABSTRACT:
The present invention relates to substituted pyrrolidinyl-3-yl-alkyl-piperidines, their stereoisomers, and pharmaceutically acceptable salts thereof and processes for preparation of the same. The compounds of the present invention are useful in their pharmacological activities such as tachykinin antagonism, especially substance P and neurokinin A antagonism, and the like. Compounds having the property of tachykinin antagonism are indicated for conditions associated with neurogenic inflammation and other diseases described herein.
REFERENCES:
patent: 3282947 (1966-11-01), Grogan et al.
patent: 4598079 (1986-07-01), Beyerle
patent: 5166136 (1992-11-01), Ward et al.
patent: 5212187 (1993-05-01), Grogan et al.
patent: 5236921 (1993-08-01), Edmonds-Alt
patent: 5317020 (1994-05-01), Emonds-Alt
patent: 5340822 (1994-08-01), Edmonds-Alt et al.
patent: 5446052 (1995-08-01), Emonds-Alt
Rubini et al. "Synthesis of isosteric methylene-oxy pseudodipeptide analogues as novel amide bond surrogate units" Tetrahedron v. 42 pp. 6039-6045 1986.
Ichinose, et al., The Lancet 340:1248-1251 (Nov. 21, 1992).
Hagiwara, et al., J. Med. Chem. 35(17):3184-3191 (1992).
Hagiwara, et al., J. Med. Chem. 35(11):2015-2025 (1992).
Van Parys, et al., Bull. Soc. Chim. Beig. 90(7):757-65 (1981).
Kametani, et al., Chemical Abstracts 72:55212n (19710).
Clark, et al., J. Med. Chem. 26(6):855-861 (1983).
Somers, et al., J. Med. Chem. 7:784-89 (1964).
Van Parys, et al., Bull Soc. Chim. Beig 90(7):749-55 (1981).
Kametani, et al., Yakugaku Zasshi 89(11)1482-7 (1969). (In Japanese).
Melloni, et al., Eur. J. Med. Chem. 26, 207-213 (1991).
Edmonds,-Alt, et al., Life Sciences, vol. 56(1), 27-32, (1995).
Daijiro Hagiwara et. al., "Design of a Novel Dipeptide Substance P Antagonist FK888 and Its Pharmacological Profile", Fujisawa Pharmacetucial Co., Ltd. May, 31, 1995.
T. Yamashita, et al., Makromol Chem. 1991, 1261-1268 (1990).
J. DiMaio, et al., J. Chem. Soc., Perkin Trans, 1989. pp. 1687-1689.
CA 107(23):217900f, Takase, et al., Tetrahedron, 42(21), 5887-5894, 1986.
CA 103(3):22829z, Takase, et al, Tetrahedron, 26(7),847-850 (1982).
Schilling, et al., "C.2., Approaches towards the Design and Synthesis of Nonpeptidic Substance-P Antagonists", Ciba-geigy Ltd., (15)207-220 Dec. 15, 1993.
Logan, et al., "Recent Advances in Neurokinin Receptor Antagonists", Annual Reports in Medicinal Chemistry (26) 43-51 (1983).
Hagiwara, et al., J. Pharmacobio-Dyn., 14, s-14 (1991).
Roubini, et al., "1,4-Piperazine-derived . . . of Substance P", Hebrew University of Jerusalem, pp. 161-162 (1991).
Chorev, et al., "Toward Nonpeptidal Substance P . . . Biological Activity", Hebrew Un of Jerusalem, 725-732, vol. 31 (1991).
Hagiwara, et l., J. Med. Chem, 36, 2266-2278, 1993.
Clark,, et al., "Principles of Phychopharmacology", Academic Press, pp. 166-167 (1970).
CA 122:105675, Miller et al. (1994).
CA 124:117093, Bichon et al. (1995).
Burkholder Timothy P.
Kudlacz Elizabeth M.
Le Tieu-Binh
Maynard George D.
Chang Ceila
Collier Kenneth J.
Merrell Pharmaceuticals Inc.
Stemerick David M.
LandOfFree
Substituted pyrrolidin-3-yl-alkyl-piperidines does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Substituted pyrrolidin-3-yl-alkyl-piperidines, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Substituted pyrrolidin-3-yl-alkyl-piperidines will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1988738